Skip to main content Skip to main menu
Main menu
  • Sign upDonate
  • Support us
    • Support us

    • Raise funds

      • Grow a moustache Raise funds for men’s health with a Mo of your own
      • Move for Movember 60km for the 60 men lost to suicide each hour across the world
      • Host a Mo-ment It’s all about having a good time for a good cause
      • Mo Your Own Way Choose your own adventure. Think big. Go bigger.
         
    • Donate

      • Give monthly Help us tackle men’s health head on, year-round
      • Give once Make a single donation directly to Movember
      • Give to a person or team Make a donation to a person or team raising funds for Movember
      • Other ways to donate Other ways you can donate to Movember's groundbreaking men's health projects
      • Philanthropy Shake up men's health with a significant gift
    • Resources and tips

      • Fundraising resources All the info you need to knock it out of the park
      • Leaderboards The heat is on. Throw your support behind a team
      • Prizes and rewards Get your hands on a range of exclusive prizes. You deserve it.
      • Movember Challenges Compete in your workplace, club or community
      • Mo Merch Sport the iconic Mo on a t-shirt, crewneck, mask, and more to help express your Mo, your way.
    • Events

      • Find an event Have fun doin’ good at an event in your area
      • The Distinguished Gentleman's Ride Supporting men’s health in timeless style
    • Back
  • About us
    • About us

    • Movember

      • Our movement About the leading charity changing the face of men’s health
      • Our cause What we stand for and why
      • Our impact You know us for the Mo, but where does the money go?
      • Our story The legend of the moustache
      • Our values The driving force at the heart of everything we do
    • Our cause areas

      • Mental health and suicide prevention Suicide is largely preventable. Here’s how we’re making a
        difference
      • Prostate cancer Globally, ~10.8M men are living with or beyond prostate cancer. Here’s what we’re doing about it
      • Testicular cancer Our approach to the world’s most common cancer among men aged 15-39
    • Financials and reports

      • Our financials The sense behind the dollars and cents
      • Annual reports Details of Movember’s 2020 financials and outcomes
      • Projects we fund What we’re funding in key cause areas
    • More information

      • Leadership and governance The leaders of the movement
      • Funding opportunities Learn about future funding opportunities
      • Publications Featured publications of research and report insights
      • Partner with us Drive business, increase employee engagement and raise your organization's profile
      • Our partners The hairy helpers who work with us
    • Back
  • Men’s health
    • Men’s health

    • Mental health and suicide prevention

      • Mental Health What to look for, when to take action, and how to support others
      • Spot the signs Can you spot a bro who’s feeling low?
      • Suicide Prevention Be a man of more words
      • Get Support Local resources for men's health.
      • Movember Conversations Walk the talk
    • Prostate cancer

      • Facts about prostate cancer What you need to know
      • True North Prostate Cancer There’s a lot that comes with prostate cancer. Learn what to expect and where to find support.
    • Testicular cancer

      • Know thy nuts Testicles – get to know what's normal and what's not
      • Nuts and Bolts The tools to tackle testicular cancer. From diagnosis, to treatment, to life afterwards –we've got your back.
    • Being a man

      • Men’s health Five things every man should know.
      • Family Man Parenting that works
      • Breaking The Ice The Movember-funded program using community hockey to teach young men how to talk about mental health.
    • Back
  • stories
    • stories

        • All Stories
        • Mental Health
        • Prostate Cancer
        • Real Stories
        • Testicular Cancer
        • Fundraising
        • In the Barber Chair
        • Where The Money Goes
    • Back
  • English
  • Français
Cookies not enabled?
The Movember website requires cookies
Please enable cookies on your browser

1 in 9 Canadian men will be diagnosed with prostate cancer in their lifetime.


Prostate cancer is the second most common cancer in men globally. Globally, more than 1.4 million men are diagnosed with prostate cancer each year.

Across Canada, there are more than 205,000 men living with and beyond prostate cancer. Many are dealing with serious side effects from treatment.

IT DOESN’T HAVE TO BE LIKE THIS.
So we’re taking action.

We’ve spent years immersed in prostate cancer research, and in that time, we’ve pushed progress forward 50 years. How? By thinking differently, collaborating globally and investing quickly in what works.

 

By 2030 ...

​We aim to halve the number of men dying from prostate cancer, and halve the number of men facing serious ongoing side effects from treatment.

Help us get there.

Sign up
 
Make a donation
 
 
 
 

“I'd like to imagine my son growing up in a world where prostate cancer can be cured. In a world where the way Dad freely talked about his health and his regular health checks isn’t unique, but the norm.”

Charlotte Connell
 

This is how we’re going to win the fight.

Our weapons of choice? Innovation and collaboration. We think differently. We back fresh and promising ideas. We unite researchers and experts across the world to chase down breakthroughs in prostate cancer, from early detection through to diagnosis, treatment and support. And we’re always steered by the question: what works for men?
It’s not just about a cure – it’s about quality of life.

The plan of attack

1. Taking action early

Helping men know the signs, symptoms and risk factors for prostate cancer.

2. Bright minds brought together

We’re bringing the best minds from around the world together to collaborate.

3. Tackling biology

Increasing the knowledge of the most lethal prostate cancer tumors, and how to slow or stop its progression.

4. Reducing side effects

No matter where they are in the world, men and their families and carers must have access to services and support.

5. Affordable treatment

We’re influencing governments to provide affordable treatment and to get new treatments into practice faster.

6. Tailored treatments, precision care

Personalized treatment is the new frontier of cancer research. From distinguishing between harmless and lethal cancers, to taking into account genes, lifestyle and environment: it means a better outcome for men.

7. Helping men make tough choices

Men need the right info to understand their diagnosis and make an informed decision when it comes to treatment.

8. Raising the standard

We’re identifying excellence in prostate cancer treatment and care, to reduce the number of men who aren’t getting the best outcome possible.

9. Global initiatives

Our three largest investments in prostate cancer are global projects that will mean better outcomes for men everywhere.

Download our investment strategy

Movember has funded more than 1,250 men’s health projects across more than 20 countries. Here’s a snapshot of our work in prostate cancer.

GLOBAL COLLABORATION

The key to progress? Collaboration. We connect researchers around the world, achieving faster results to reach men sooner. We share our successes and our failures so the scientific community doesn’t lose time to duplicating research.

Global Action Plan

Movember works with leading researchers from around the world to identify key research areas to work together on. Since 2011, Movember has committed $43 million AUD to seven key global research projects in prostate and testicular cancer:
  • GAP1: Prostate Cancer Biomarkers
  • GAP2: Advanced Prostate Cancer Imaging
  • GAP3: Prostate Cancer Active Surveillance
  • GAP4: Prostate Cancer Exercise and Metabolic Health
  • GAP5: Testicular Cancer TIGER Trial
  • GAP6: Oligometastic Prostate Cancer
  • GAP7: True North Testicular Cancer Program (Nuts and Bolts)
 
 

True North

True North is a global prostate cancer program developed by Movember to help improve outcomes and quality of life for men diagnosed with prostate cancer. With the help of clinicians, researchers, health organisations and user feedback, True North aims to provide information, resources and support to help men navigate the prostate cancer journey.
Visit the True North website
 
 

Clinical quality

Our clinical quality initiatives are transforming prostate cancer healthcare globally by building a better understanding of men’s experiences. By compiling reports from both doctors and patients throughout diagnosis and treatment – and comparing these experiences across regions – we’re improving the quality of prostate cancer care, and reducing treatment variation by continually learning, benchmarking and promoting excellence. These initiatives are active in 18 countries.

The world's first precision medicine drug for treating prostate cancer 

Movember-funded research by Dr Joaquin Mateo contributed to the approval of olaparib in the United States for metastatic, castration-resistant prostate cancer (advanced prostate cancer).  Olaparib works by targeting cancer cell’s ability to repair damage to their DNA. Read on.

Patient Reported Outcome Measure (PROMs)

The Prostate Cancer Patient Reported Outcome Measure (PROMs) is a survey of all men diagnosed with Prostate Cancer at various timepoints in their clinical care. The survey aims to understand more about the experiences of a man with prostate cancer and then make recommendations on how health services can adapt to improve a man’s health and wellbeing as well as influence policy.

Advances in prostate cancer imaging

18F-Fluciclovine is a novel radiotracer for whole-body imaging of prostate cancer tumours using Positron Emission Tomography (PET). Approved in the United States for detection of recurrent prostate cancer in men with elevated PSA levels after previous treatment, it is now marketed by Blue Earth Diagnostics as Axumin®.

Latest breakthroughs in new drugs

Enzalutamide and abiraterone are two androgen receptor-targeted drugs approved in the United States for men whose prostate cancer has spread to other areas of their body. Movember funding for the Prostate Cancer Clinical Trial Consortium supported pivotal clinical research which contributed to the approval of Enzalutamide (Xtandi®) and abiraterone (Zytiga®).

Local impact

In addition to large-scale efforts that span the globe, we’re also making strides for men in Canada.

A trial looking into the accuracy of MRI technology for prostate cancer diagnosis

The PRECISE trial, led by Dr Lawrence Klotz, is looking at whether magnetic resonance imaging (MRI) allows more accurate diagnosis of prostate cancer compared to the standard systematic prostate tissue biopsy. Currently, the use of biopsy to confirm the aggressiveness of prostate cancer in men with high PSA levels or abnormal DRE can either over- or under-detect cancer, leading to unnecessary treatment or not appropriately treating clinically significant disease.

Research into a new class of drugs

The TAG2 Project, led by Dr Tak Mak and his team, is studying a new class of drug targeting a different signalling pathway in prostate cancer growth, that will hopefully add to treatments available for advanced disease. Prostate cancer becomes more difficult to treat when the disease progresses to advanced prostate cancer and, in some cases, treatment resistance develops.

Canadian Prostate Cancer Genome Network (CPC-GENE)

The Canadian Prostate Cancer Genome Network (CPC-GENE) has resulted in the world’s most comprehensive genetic analysis of the prostate cancer tumours. Research from this network has advanced our understanding of prostate cancer, including the identification of a DNA signature of aggressive disease as well as changes in DNA that links prostate cancer evolution to disease severity. Most importantly, data from CPC-GENE serve as a rich resource for new diagnostic tests and treatments, and future research.

See all prostate cancer projects

WE’VE MADE EPIC INROADS

But there’s more to be done. Men with prostate cancer still face invasive treatments, serious treatment-related side effects and life or death questions. On top of all that, awareness around early detection has a long way to go. But we’re on it.

To get to where we want to be by 2030,
we need your help.

Join up
 
Make a donation
 

Proudly grown by our official partners

Our promotional partners

Project Funding Partners

Sign up Donate
  • Support us

    • Grow a moustache
    • Move for Movember
    • Host a Mo-ment
    • Mo Your Own Way
    • Fundraising resources
    • Leaderboards
    • Prizes and rewards
    • Movember Challenges
    • Give monthly
    • Give once
    • Give to a person or team
    • Other ways to donate
    • Find an event
    • The Distinguished Gentleman's Ride
    • Mo Merch
    • Philanthropy
  • About us

    • Our movement
    • Our cause
    • Our impact
    • Our story
    • Our values
    • Mental health and suicide prevention
    • Prostate cancer
    • Testicular cancer
    • Our financials
    • Annual reports
    • Projects we fund
    • Leadership and governance
    • Funding opportunities
    • Publications
    • Partner with us
    • Our partners
  • Men’s health

    • Mental Health
    • Facts about prostate cancer
    • Know thy nuts
    • Men’s health
    • Spot the signs
    • Suicide Prevention
    • Get Support
    • Movember Conversations
    • Family Man
    • True North Prostate Cancer
    • Nuts and Bolts
    • Breaking The Ice
  • stories

    • Stories
  • More

    • Worldwide
    • Media Room
    • Financials
    • FAQ
    • Contact Us
    • Policies
    • Terms
  • Languages

    • English
    • Français
  • Social

    facebook Click here! youtube twitter Linked In
Movember Canada is a registered charity number 84821 5604 RR0001
© 2022 Movember. All rights reserved.